About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 19 Issue 5 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 1855 results:

Case report

Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis

Stella De Nicola, Alessio Aghemo, Maria Rosaria Campise, Roberta D’Ambrosio, Maria Grazia Rumi, Piergiorgio Messa, Massimo Colombo

Antiviral Therapy 2014; 19:527-531


Short communication

Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa

Gilles Wandeler, Florian Gerber, Julia Rohr, Benjamin H Chi, Catherine Orrell, Cleophas Chimbetete, Hans Prozesky, Andrew Boulle, Christopher J Hoffmann, Thomas Gsponer, Matthew P Fox, Marcel Zwahlen, Matthias Egger, IeDEA Southern Africa

Antiviral Therapy 2014; 19:521-525


Original article

Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate

Marc Bifano, Heather Sevinsky, Carey Hwang, Hamza Kandoussi, Hao Jiang, Dennis Grasela, Richard Bertz

Antiviral Therapy 2014; 19:511-519


Original article

Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1

Namiki Izumi, Osamu Yokosuka, Norifumi Kawada, Yukio Osaki, Kazuhide Yamamoto, Michio Sata, Hiroki Ishikawa, Tomoko Ueki, Wenhua Hu, Fiona McPhee, Eric A Hughes, Hiromitsu Kumada

Antiviral Therapy 2014; 19:501-510


Original article

A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection

Fumitaka Suzuki, Joji Toyota, Kenji Ikeda, Kazuaki Chayama, Satoshi Mochida, Norio Hayashi, Hiroki Ishikawa, Hidetaka Miyagoshi, Wenhua Hu, Fiona McPhee, Eric A Hughes, Hiromitsu Kumada

Antiviral Therapy 2014; 19:491-499


Original article

Virological escape in HCV genotype-1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b

Fiona McPhee, Dennis Hernandez, Nannan Zhou, Fei Yu, Joseph Ueland, Aaron Monikowski, Kazuaki Chayama, Joji Toyota, Namiki Izumi, Osamu Yokosuka, Norifumi Kawada, Yukio Osaki, Eric A Hughes, Hideaki Watanabe, Hiroki Ishikawa, Hiromitsu Kumada

Antiviral Therapy 2014; 19:479-490


Original article

Treatment of hepatitis C with an interferon-based lead-in phase: a perspective from mathematical modelling

Libin Rong, Jeremie Guedj, Harel Dahari, Alan S Perelson

Antiviral Therapy 2014; 19:469-477


Original article

Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience

Zaigham Abbas, Mohammad S Memon, Hammad Mithani, Wasim Jafri, Saeed Hamid

Antiviral Therapy 2014; 19:463-468


Original article

Genetic background for development of resistance mutations within the HCV NS3 protease–helicase in direct acting antiviral naive patients

Georgios Grammatikos, Cassandra B Jabara, Monazza Q Ahmad, Eva Herrmann, Stefan Zeuzem, Christoph Welsch

Antiviral Therapy 2014; 19:455-461


Original article

Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays – implications for response-guided therapy in genotype 1 infections

Ninon Taylor, Elisabeth Haschke-Becher, Richard Greil, Michael Strasser, Hannes Oberkofler

Antiviral Therapy 2014; 19:449-454


Page:
Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.